Tirzepatide（替西帕肽）中国申报上市，是当下降糖之王！
US$ 21.87
dr. reddy's labs glp-1 receptor agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Current Insights, Advantages and Challenges
Description
The HR for the expanded MACE outcome was similar to that of the primary outcome (HR 0.82
This decline may be due to the decreased GLP-1 secretion or impairment of L-cell development [15,16,17,18]
Pure osmotic laxatives without bulk-forming fiber have become the preferred standard for managing these specific medication side effects
Why have GLP-1 receptors historically been difficult to target with small molecules, and what has changed to make oral versions possible now
